Emcure Pharmaceuticals Ltd

Common Name

Emcure Pharmaceuticals

Country

India

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

6,731

Ticker

EMCURE

Exchange

NATIONAL STOCK EXCHANGE OF INDIA

Website

www.emcure.com

Description

Emcure Pharmaceuticals Ltd. is a leading pharmaceutical company specializing in the production and distribution of a diverse range of healthcare solutions. Primarily engaged in the formulation and man... Show more

Income Statement Balance Sheet Group Entities

Emcure Pharmaceuticals's Financial Statements Preview

Below are the financial statements of Emcure Pharmaceuticals, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in billions of INR	2025 as of 2025-03-31	2024 as of 2024-03-31
Assets	—	—
Non-current assets	—	—
Property, plant and equipment	19.54^a	19.49^a
Capital work-in-progress	1.24^a	1.32^a
Right-of-use assets	3.49^a	3.16^a
Goodwill	3.68^a	3.79^a
Other intangible assets	5.26^a	4.81^a
Intangible assets under development	0.53^a	0.27^a
Financial assets	—	—
Investments	0.19^a	0.18^a
Other non current financial assets	0.39^a	0.41^a
Deferred tax assets (net)	1.11^a	0.97^a
Income tax assets (net)	0.94^a	0.87^a
Other non-current assets	0.39^a	0.19^a
Total non-current assets	36.77^a	35.46^a
Current assets	—	—
Inventories	19.32^a	15.25^a
Financial assets	—	—
Investments	0.76^a	3^a
Trade receivables	20.02^a	18.59^a
Cash and cash equivalents	1.56^a	1.69^a
Bank balances other than above	0.1^a	0.63^a
Other current financial assets	0.53^a	0.69^a
Other current assets	3.28^a	2.7^a
Assets held for sale	0^a	0.05^a
Total current assets	45.56^a	42.6^a
Total assets	82.33^a	78.06^a
Equity	—	—
Equity share capital	1.89^a	1.81^a
Other equity	42.57^a	27.71^a
Equity attributable to owners of the holding company	44.46^a	29.52^a
Non-controlling interest	1.95^a	1.69^a
Total equity	46.42^a	31.22^a
Liabilities	—	—
Non-current liabilities	—	—
Financial liabilities	—	—
Borrowings	1.9^a	7.67^a
Lease liabilities	2.57^a	2.16^a
Other non current financial liabilities	2.94^a	2.95^a
Provisions	0.48^a	0.43^a
Deferred tax liabilities (net)	1.2^a	1.37^a
Other non-current liabilities	0.14^a	0.16^a
Total non-current liabilities	9.23^a	14.74^a
Current liabilities	—	—
Financial liabilities	—	—
Borrowings	5.42^a	13.21^a
Lease liabilities	0.34^a	0.32^a
Trade payables	—	—
Total outstanding dues of micro and small enterprises	0.32^a	0.17^a
Total outstanding dues to others	14.47^a	12.92^a
Other current financial liabilities	3.26^a	3.04^a
Other current liabilities	1.21^a	1.45^a
Provisions	0.55^a	0.46^a
Current tax liabilities (net)	1.12^a	0.53^a
Total current liabilities	26.68^a	32.1^a
Total liabilities	35.91^a	46.84^a
Total equity and liabilities	82.33^a	78.06^a

Download Data

Verified Sources Behind Emcure Pharmaceuticals’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Emcure Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.

a. Emcure Pharmaceuticals's Annual Report 2025

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Emcure Pharmaceuticals Ltd

Emcure Pharmaceuticals's Financial Statements Preview

Verified Sources Behind Emcure Pharmaceuticals’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Alkem Laboratories Ltd

IPCA Laboratories Ltd

Piramal Pharma Ltd

Glenmark Pharmaceuticals Ltd

Natco Pharma Ltd

J B Chemicals and Pharmaceuticals Ltd